Le Lézard
Classified in: Health, Business
Subjects: TNM, MAT

In Vitro Sciences Expands Presence in Arizona With Acquisition of Another Leading Fertility Center

AVON, Conn., March 2, 2020 /PRNewswire-PRWeb/ -- In Vitro Sciences (IVS), a prominent network of fertility centers, in partnership with Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility operating in the greater Phoenix area, announced today that it acquired Troché Fertility Centers (TFC), a highly-regarded and long-standing fertility center based in Glendale, AZ. This acquisition solidifies the growing position of IVS and AFC throughout Arizona and sets the course for continued expansion throughout the Southwest region.

With an ambitious expansion plan in mind, IVS made the initial entry into the Arizona market with a strategic partnership with AFC in October of 2019. AFC serves patients from all over Arizona, with offices in Scottsdale and Mesa. Now, the acquisition of TFC will allow AFC to continue their mission of expanding the availability of RE services to patients struggling with fertility challenges in the Northwest region of Phoenix and beyond.

Since 1992, TFC has guided and supported patients on the journey of turning their dream of parenthood into a reality. With a primary location in Glendale, Dr. Vladimir Troché and TFCs' in vitro fertilization (IVF) program has provided personalized care to patients from all over Arizona, the United States, Mexico, and Canada.

Beth Zoneraich, Market President of IVS, and Chief Executive Officer of AFC, commented "In Vitro Sciences and Advanced Fertility Care joined forces with the mission of creating widespread access to the highest quality care for patients facing fertility issues, and acquiring Troché Fertility Centers was the natural next step to our growth plans. Troché Fertility Centers and Dr. Vladimir Troché, have stellar reputations in Arizona and we look forward to applying our respective strengths to advancing the care coordination in the reproductive field."

Vladimir Troché, MD, Medical Director and founder of Troché Fertility Centers, stated "We are excited to work with both IVS and AFC. We have a shared vision for providing the highest quality of care for families struggling with infertility and believe this arrangement will enhance our efforts to bring the most advanced, innovative care to women in our communities. Working together allows us to maintain our focus on the best patient care while simultaneously moving forward."

About Advanced Fertility Care

Advanced Fertility Care (AFC) serves patients from all over Arizona with the latest fertility treatment options including IUI, IVF, ICSI, embryo biopsy and genetic testing. With primary offices in Scottsdale and Mesa, AFC consistently demonstrates high pregnancy success rates well above national averages, enabled by the best technology and treatment protocols available. AFC has been recognized as a Center of Excellence by every major insurer.

About In Vitro Sciences

With a 22-year history in the fertility arena and a comprehensive suite of business management services, In Vitro Sciences (IVS) partners with reproductive endocrinology practices across the United States. IVS partners to offer strategic opportunities for independent practices, including: implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, marketing, and risk management services IVS's unique partnership model enables physicians and physician groups to maintain their independence while leveraging the resources of a national organization.

About Troché Fertility Centers

Since 1992, Troché Fertility Centers (TFC) has offered successful fertility treatments to couples and individuals in the Phoenix metropolitan, Dr. Vladmir Troché is considered a fertility pioneer in the valley. With a primary location in Glendale, AZ, Troché Fertility Centers' in vitro fertilization (IVF) program have produced pregnancy success rates consistently above the national average.


SOURCE In Vitro Sciences

These press releases may also interest you

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Octapharma USA and BioMatrix Specialty Pharmacy are supporting a new investigator-initiated research study led by Kelly McCants, M.D., Medical Director of the Norton Heart & Vascular Institute in Louisville, Ky., focused on treating patients with the...

at 09:04
New brand CarryOntm has launched sparkling CBD waters as well as a brand mission to normalize the pursuit of mental wellbeing.  With over 56% of Americans reporting negative effects on their mental wellbeing, CarryOntm believes that the pursuit of...

at 09:00
InspectIR Systems, LLC, a purpose-driven company with proprietary measurement methods, devices and tools, has begun clinical trials aimed at detecting the novel coronavirus (COVID-19). InspectIR partnered with University of North Texas Associate...

at 09:00
CAN Community Health announced that Tampa Family Pharmacy founders Haley Miller and Crystal Campbell have resigned effective immediately and sold their remaining interest to CAN Community Health to spend more time with their respective families....

at 09:00
PTC Therapeutics, Inc. today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5 at 10:00 a.m. ET....

News published on 2 march 2020 at 14:00 and distributed by: